Abstract
The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Current Nutrition & Food Science
Title: Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?
Volume: 3 Issue: 2
Author(s): J. Delarue, V. Le Guen, G. Allain, C. Corporeau and S. Guillerm
Affiliation:
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Abstract: The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Export Options
About this article
Cite this article as:
Delarue J., Le Guen V., Allain G., Corporeau C. and Guillerm S., Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?, Current Nutrition & Food Science 2007; 3 (2) . https://dx.doi.org/10.2174/157340107780598663
DOI https://dx.doi.org/10.2174/157340107780598663 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Coronary Calcium Risk Score and Cardiovascular Risk
Current Vascular Pharmacology Biological Consequences of Dysfunctional HDL
Current Medicinal Chemistry A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
Current Vascular Pharmacology Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropathy, Proteinuria Estimation, Diagnosing and Monitoring
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Meta-heuristic Techniques to Train Artificial Neural Networks for Medical Image Classification: A Review
Recent Advances in Computer Science and Communications Recurrent Gastrointestinal Bleeding in a Patient with Eisenmenger Syndrome Using Bosentan
Current Drug Safety Modulators of the Vascular Endothelin Receptor in Blood Pressure Regulation and Hypertension
Current Molecular Pharmacology Pharmacokinetics and Biotransformation of Tea Polyphenols
Current Drug Metabolism Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients
Current Diabetes Reviews Structural and Functional Characterization of a Mutant of Pseudocerastes persicus Natriuretic Peptide
Protein & Peptide Letters Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
Current Medicinal Chemistry Cardiac Chamber Volumetric Assessment Using 3D Ultrasound - A Review
Current Pharmaceutical Design Reductions in Medications with Substantial Weight Loss with Behavioral Intervention
Current Clinical Pharmacology Perivascular Inflammation and Hypertensive Cardiovascular Remodeling
Current Hypertension Reviews Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry Development of New Drugs for COPD
Current Medicinal Chemistry Editorial [Hot Topic:Modifying Cardiovascular Risk Factors: Newer Insights and Preventive Measures (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypercholesterolemia and Endothelium Dysfunction: Role of Dietary Supplementation as Vascular Protective Agents
Current Vascular Pharmacology